Just one example of a Big Pharma licensing deal earlier this year for US$2.2Billion full face value.
https://dcatvci.org/p
harma-news/7018-novartis-beigene-close-2-2-bn-licensing-deal-for-oncology-drug
https://www.fiercepharma.com/marketing/novartis-takes-celgene-s-baton-licensing-beigene-s-tislelizumab-as-own-pd-1-fails-to
Below 5 year growth of Beigene 's market cap... $1billion to $30 billion.
Explains why the fund managers have a very healthy appetite for Imu right now. They're not here to flip it at 40c.
Multiple licensing deals across the pipeline will see
that type of growth replicated over time.
- Forums
- ASX - By Stock
- Why IMU is a multi multi bagger
Just one example of a Big Pharma licensing deal earlier this...
-
-
- There are more pages in this discussion • 24,010 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $376.9M |
Open | High | Low | Value | Volume |
5.1¢ | 5.2¢ | 4.9¢ | $1.233M | 24.37M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 1084013 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 1226204 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 1057643 | 0.051 |
32 | 2619040 | 0.050 |
44 | 5135321 | 0.049 |
22 | 2807028 | 0.048 |
16 | 1124963 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 1100714 | 12 |
0.053 | 1188301 | 5 |
0.054 | 1004769 | 6 |
0.055 | 862370 | 8 |
0.056 | 433333 | 4 |
Last trade - 13.55pm 03/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online